Jin Medical turns to FY26 H1 net loss of USD 0.2 million; revenue falls 9.7% to USD 8.9 million

• Jin Medical posted revenue of USD 8.9 million for the six months ended March 31, 2026, down 9.7% year over year.
• It turned to a net loss of USD 0.2 million from net income of USD 0.01 million; basic and diluted loss per share was USD 0.01.
• Gross margin widened 2.6 percentage points to 26.9% as gross profit held at USD 2.4 million.
• Wheelchair revenue slipped 1.4% to USD 7.1 million on lower orders from Japan’s Nissin amid yen weakness; wheelchair components rose 9.9% to USD 1.1 million.
• Other products fell 59.1% to USD 0.7 million after electric scooter sales were halted; cash was USD 9.1 million with USD 21 million in short-term investments.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jin Medical International Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN18735) on August 04, 2026, and is solely responsible for the information contained therein.